동향
Home > DB > 동향
| The joint IAEA, EANM, AND SNMMI practical guidance on peptide receptor radionuclide therapy(PRRNT) in neuroendocrine tumours | |||
|---|---|---|---|
| 분류 | Nuclear medicine, Guidance | 조회 | 2900 |
| 발행년도 | 2013 | 등록일 | 2015-10-02 |
| 출처 | EANM (바로가기) | ||
|
Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy involving the systemic administration of a radiolabelled peptide designed to target with high affinity and specificity receptors overexpressed on tumours.
(후략)
|
|||
|
|
이전글
다음글